Home › Calculator › PTGX Dividend Calculator 2026
PTGX Dividend Calculator 2026
No dividendHealthcareProtagonist Therapeutics, Inc. · NASDAQ
Price: $138.43 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
PTGX is not a dividend-focused stock
PTGX pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
PTGX Dividend Yield
Protagonist Therapeutics, Inc. (PTGX) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When PTGX pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Protagonist Therapeutics, Inc. (PTGX) — Dividend Analysis 2026
Protagonist Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering and advancing peptide-based therapies. Their research primarily focuses on treatments for hematological and blood conditions, as well as inflammatory and immune-mediated disorders. The company's pipeline features rusfertide (PTG-300), an injectable hepcidin mimetic currently undergoing Phase II clinical trials for the management of polycythemia vera, hereditary hemochromatosis, and other blood-related ailments. Also in Phase II development is PN-943, an oral peptide engineered as a specific antagonist of alpha-4-beta-7 integrin, intended for addressing inflammatory bowel disease (IBD). Furthermore, they are progressing PN-235, an orally administered antagonist specifically targeting the interleukin-23 receptor, designed for both IBD and various non-IBD therapeutic applications. Protagonist Therapeutics maintains a licensing and collaborative agreement with Janssen Biotech, Inc. Founded in 2006, the company's headquarters are located in Newark, California.
PTGX Dividend & DRIP — Frequently Asked Questions
Does PTGX pay a dividend?
No. Protagonist Therapeutics, Inc. (PTGX) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of PTGX?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does PTGX have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. PTGX has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to PTGX
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full PTGX DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open PTGX position with:
🌍 PTGX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold PTGX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 PTGX Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 PTGX Dividend Payment Schedule
PTGX pays quarterly — 4 times per year. Ex-div: —.
📊 PTGX vs Healthcare Benchmarks
How PTGX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for PTGX sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ PTGX Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2026-09-30 | 5,312 | $12.17 | $64.6K | ||
| M-Exempt | 2026-09-30 | 15,650 | $19.19 | $300.3K | ||
| Sale | 2026-09-30 | 12,595 | $141.77 | $1.79M | ||
| M-Exempt | 2026-09-30 | 28,438 | $23.42 | $666.0K | ||
| M-Exempt | 2026-09-30 | 9,229 | $38.98 | $359.7K | ||
| Sale | 2026-09-30 | 46,034 | $141.78 | $6.53M | ||
| M-Exempt | 2026-09-30 | 15,650 | $19.19 | $300.3K | ||
| M-Exempt | 2026-09-30 | 28,438 | $23.42 | $666.0K | ||
| M-Exempt | 2026-09-30 | 9,229 | $38.98 | $359.7K | ||
| M-Exempt | 2026-09-30 | 5,312 | $12.17 | $64.6K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare PTGX with peers: PTGX vs ACLX · PTGX vs AKRO · PTGX vs ALKS
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the PTGX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Protagonist Therapeutics, Inc. (PTGX) is currently trading at $138.43, 14% below its 52-week high. It does not currently pay a regular dividend.
Does PTGX Pay a Dividend? Protagonist Therapeutics, Inc. Dividend Status
Protagonist Therapeutics, Inc. (PTGX) is a healthcare stock trading at $138.43. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest PTGX News
LiveProjected your PTGX DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.